| Stage | CNM | % of rev | AKAM | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.1B | 100.00% | $1.1B | 100.00% | CNM ×1.95 |
| Gross profit | $573M | 26.71% | $614M | 55.81% | AKAM +29.1pp |
| Operating income | $227M | 10.58% | $80M | 7.30% | CNM +3.3pp |
| Pre-tax income | $193M | 9.00% | $100M | 9.10% | AKAM +0.1pp |
| Net income | $150M | 6.99% | $79M | 7.22% | AKAM +0.2pp |
| Stage | CNM | AKAM | Gap · A − B |
|---|---|---|---|
| Revenue | $2.1B100.00% | $1.1B100.00% | CNM ×1.95 |
| Gross profit | 26.71%$573M | 55.81%$614M | AKAM +29.1pp |
| Operating income | 10.58%$227M | 7.30%$80M | CNM +3.3pp |
| Pre-tax income | 9.00%$193M | 9.10%$100M | AKAM +0.1pp |
| Net income |
| 6.99%$150M |
| 7.22%$79M |
| AKAM +0.2pp |